Additionally, cases of hormonal triple-negative breast cancer (estrogen-receptor (ER), progesterone-receptor (PR), and human epidermal growth factor receptor-2 (HER-2)) are seen in only 10% of breast cancers [7]. This evidence concerns the gene PGR and triple-negative breast carcinoma.